Other reports have also shown that polymorphisms in NER genes (XPA, XPC, ERCC2/XPD, ERCC1) are implicated in the onset and progression of HNSCC, as well as the response to therapy.54 This evidence concerns the gene ERCC2 and head and neck squamous cell carcinoma.